Narrowband UVB phototherapy for early-stage mycosis fungoides

Journal of the American Academy of Dermatology

Volumn 47, Issue 2, 2002, Pages 191-197

  Gathers, Raechele Cochran ^a   Scherschun, Lubomira ^a   Malick, Farah ^a   Fivenson, David P ^a   Lim, Henry W ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; MALE; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; SKIN BIOPSY; SKIN LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

EID: 0036695905     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120911     Document Type: Article

References (27)

1. Duvic M, Cather J. Emerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin 2000;18:147-56.
2. Kim Y, Hoppe R. Mycosis fungoides and the Sézary syndrome. Semin Oncol 1999;26:276-89.
3. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996;132:1309-13.
4. Duncan K, Heald P. Cutaneous T-cell lymphoma: centuries of controversy. Semin Cutan Med Surg 1998;17:133-40.
5. Herrmann JJ, Roenigk HH, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, et al. Treatment of mycosis fungoides with phototherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995;33:234-42.
6. Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early stage cutaneous T-cell lymphoma. Arch Dermatol 1992;128:931-3.
7. Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1031-56.
8. Gilchrest BA, Parrish JA, Tanenbaum L, Hayes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976;38:683-9.
9. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
10. Greene I, Cox A. Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light. Arch Dermatol 1979; 115:1200-2.
11. Gupta AK, Anderson TF. Psoralen photochemotherapy. J Am Acad Dermatol 1987;17:703-34.
12. Hoppe RT, Cox RS, Fuks Z, Price NM, Bagshaw MA, Farber EM. Electron-beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979;63:691-700.
13. Hoppe RT. The management of mycosis fungoides at Stanford-standard and innovative treatment programs. Leukemia 1991; 5(Suppl 1):46-8.
14. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B: Biol 1997;38:99-106.
15. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H. Narrowband UVB phototherapy vs. photochemotherapy in the treatment of chronic plaque-type psoriasis. Arch Dermatol 1999;135:519-24.
16. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. Comparison of narrow-band UVB phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990;70:212-5.
17. Hofer A, Cerroni L, Keri H, Wolf P. Narrowband (311-nm) UVB therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999;135:1377-80.
18. Clark C, Dawe R, Evans A, Lowe G, Ferguson J. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 2000;136:748-52.
19. Bunn PJ, Lamberg S. Report of the committee on staging and classification of cutaneous T-cell lymphoma. Cancer Treat Rep 1979;63:725-8.
20. Green C, Ferguson J, Lakshmipathi T. 311 nm UVB phototherapy-an effective treatment for psoriasis. Br J Dermatol 1988;119:691-6.
21. Coven TR, Burack LH, Gilleaudeau P, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997;133:1514-22.
22. Morison WL. Phototherapy and photochemotherapy: an update. Semin Cutan Med Surg 1999;18:297-306.
23. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995;132:956-63.
24. Kochevar IE, Pathak MA, Parrish JA. Photophysics, photochemistry, and photobiology. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz 51, et al, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 220-9.
25. Akaraphanth R, Douglas MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6 1/2-year follow-up of 9 patients. J Am Acad Dermatol 2000;42:33-9.
26. DeGruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, editors. The fundamental basis of phototherapy. Milan, Italy: OEMF spa; 1996. p. 153-70.
27. Young A. Carcinogenicity of UVB phototherapy assessed. Lancet 1995;345:1431-2.